Bradley D. Anawalt

5.7k total citations
71 papers, 4.1k citations indexed

About

Bradley D. Anawalt is a scholar working on Endocrinology, Diabetes and Metabolism, Reproductive Medicine and Molecular Biology. According to data from OpenAlex, Bradley D. Anawalt has authored 71 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Endocrinology, Diabetes and Metabolism, 29 papers in Reproductive Medicine and 20 papers in Molecular Biology. Recurrent topics in Bradley D. Anawalt's work include Hormonal and reproductive studies (54 papers), Sexual Differentiation and Disorders (20 papers) and Sperm and Testicular Function (15 papers). Bradley D. Anawalt is often cited by papers focused on Hormonal and reproductive studies (54 papers), Sexual Differentiation and Disorders (20 papers) and Sperm and Testicular Function (15 papers). Bradley D. Anawalt collaborates with scholars based in United States, Australia and United Kingdom. Bradley D. Anawalt's co-authors include Alvin M. Matsumoto, William J. Bremner, John K. Amory, Stephanie T. Page, J. Lisa Tenover, Karen L. Herbst, Andrea D. Coviello, Christopher W. Forsberg, Nicholas L. Smith and Molly M. Shores and has published in prestigious journals such as The Lancet, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

In The Last Decade

Bradley D. Anawalt

70 papers receiving 4.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bradley D. Anawalt United States	36	2.7k	1.3k	1.1k	716	669	71	4.1k
Ann J. Conway Australia	34	2.5k 0.9×	1.6k 1.2×	1.0k 0.9×	615 0.9×	661 1.0×	81	3.9k
Vito Angelo Giagulli Italy	31	2.2k 0.8×	922 0.7×	779 0.7×	392 0.5×	533 0.8×	137	3.9k
György Bártfai Hungary	25	2.4k 0.9×	879 0.7×	789 0.7×	788 1.1×	847 1.3×	56	4.0k
Krzysztof Kula Poland	29	3.0k 1.1×	1.4k 1.0×	1.3k 1.2×	428 0.6×	1.0k 1.6×	104	4.8k
Maria A. Yialamas United States	14	1.7k 0.6×	647 0.5×	566 0.5×	304 0.4×	670 1.0×	33	2.6k
Richard V. Clark United States	32	2.5k 0.9×	637 0.5×	845 0.8×	351 0.5×	439 0.7×	63	4.1k
Daniele Gianfrilli Italy	37	2.0k 0.7×	773 0.6×	1.0k 0.9×	250 0.3×	530 0.8×	132	4.2k
T. Hugh Jones United Kingdom	31	3.4k 1.2×	644 0.5×	984 0.9×	223 0.3×	1.3k 2.0×	65	4.7k
Mohit Khera United States	37	2.8k 1.0×	663 0.5×	1.2k 1.1×	361 0.5×	798 1.2×	207	5.0k
Giovanni Spera Italy	38	1.9k 0.7×	776 0.6×	1.2k 1.1×	460 0.6×	556 0.8×	106	4.8k

Countries citing papers authored by Bradley D. Anawalt

Since Specialization

Citations

This map shows the geographic impact of Bradley D. Anawalt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bradley D. Anawalt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bradley D. Anawalt more than expected).

Fields of papers citing papers by Bradley D. Anawalt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bradley D. Anawalt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bradley D. Anawalt. The network helps show where Bradley D. Anawalt may publish in the future.

Co-authorship network of co-authors of Bradley D. Anawalt

This figure shows the co-authorship network connecting the top 25 collaborators of Bradley D. Anawalt. A scholar is included among the top collaborators of Bradley D. Anawalt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bradley D. Anawalt. Bradley D. Anawalt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Anawalt, Bradley D.. (2023). Barbells and Ken: Bodybuilders and Androgenic Steroid Abuse. The Journal of Clinical Endocrinology & Metabolism. 109(6). e1452–e1453. 1 indexed citations

Grossmann, Mathis, Channa Jayasena, & Bradley D. Anawalt. (2023). Approach to the Patient: The Evaluation and Management of Men ≥50 Years With Low Serum Testosterone Concentration. The Journal of Clinical Endocrinology & Metabolism. 108(9). e871–e884. 11 indexed citations

Anawalt, Bradley D. & Alvin M. Matsumoto. (2022). Aging and androgens: Physiology and clinical implications. Reviews in Endocrine and Metabolic Disorders. 23(6). 1123–1137. 28 indexed citations

Thirumalai, Arthi & Bradley D. Anawalt. (2022). Epidemiology of Male Hypogonadism. Endocrinology and Metabolism Clinics of North America. 51(1). 1–27. 18 indexed citations

Yeap, Bu B., Ross J. Marriott, Leen Antonio, et al.. (2020). Serum Testosterone is Inversely and Sex Hormone-binding Globulin is Directly Associated with All-cause Mortality in Men. The Journal of Clinical Endocrinology & Metabolism. 106(2). e625–e637. 38 indexed citations

Anawalt, Bradley D., Mara Y. Roth, John K. Amory, et al.. (2019). Combined nestorone–testosterone gel suppresses serum gonadotropins to concentrations associated with effective hormonal contraception in men. Andrology. 7(6). 878–887. 37 indexed citations

Wu, Sherry Y., Ronald S. Swerdloff, Youngju Pak, et al.. (2018). Safety and Pharmacokinetics of Single-Dose Novel Oral Androgen 11 β -Methyl-19-Nortestosterone-17 β -Dodecylcarbonate in Men. The Journal of Clinical Endocrinology & Metabolism. 104(3). 629–638. 34 indexed citations

Wu, Sherry Y., Arthi Thirumalai, Ronald S. Swerdloff, et al.. (2018). Preventing secondary exposure to women from men applying a novel nestorone/testosterone contraceptive gel. Andrology. 7(2). 235–243. 14 indexed citations

Shoeb, Marwa, Susan E. Merel, Molly Blackley Jackson, & Bradley D. Anawalt. (2012). “Can we just stop and talk?” patients value verbal communication about discharge care plans. Journal of Hospital Medicine. 7(6). 504–507. 19 indexed citations

10.

Anawalt, Bradley D., et al.. (2011). Assessment and management of low bone density in inflammatory bowel disease and performance of professional society guidelines1. Inflammatory Bowel Diseases. 17(10). 2122–2129. 46 indexed citations

11.

Roth, Mara Y., John K. Amory, Alvin M. Matsumoto, et al.. (2010). Serum LH Correlates Highly With Intratesticular Steroid Levels in Normal Men. Journal of Andrology. 31(2). 138–145. 39 indexed citations

12.

Liu, Peter Y., Ronald S. Swerdloff, Bradley D. Anawalt, et al.. (2008). Determinants of the Rate and Extent of Spermatogenic Suppression during Hormonal Male Contraception: An Integrated Analysis. The Journal of Clinical Endocrinology & Metabolism. 93(5). 1774–1783. 86 indexed citations

13.

Amory, John K., Stephanie T. Page, Bradley D. Anawalt, et al.. (2007). Elevated End‐of‐Treatment Serum INSL3 Is Associated With Failure to Completely Suppress Spermatogenesis in Men Receiving Male Hormonal Contraception. Journal of Andrology. 28(4). 548–554. 53 indexed citations

14.

Page, Stephanie T., John K. Amory, F. DuBois Bowman, et al.. (2005). Exogenous Testosterone (T) Alone or with Finasteride Increases Physical Performance, Grip Strength, and Lean Body Mass in Older Men with Low Serum T. The Journal of Clinical Endocrinology & Metabolism. 90(3). 1502–1510. 435 indexed citations

15.

McLachlan, Robert I., David Robertson, Enid Pruysers, et al.. (2004). Relationship between Serum Gonadotropins and Spermatogenic Suppression in Men Undergoing Steroidal Contraceptive Treatment. The Journal of Clinical Endocrinology & Metabolism. 89(1). 142–149. 49 indexed citations

16.

Amory, John K., Nelson B. Watts, Kirk A. Easley, et al.. (2004). Exogenous Testosterone or Testosterone with Finasteride Increases Bone Mineral Density in Older Men with Low Serum Testosterone. The Journal of Clinical Endocrinology & Metabolism. 89(2). 503–510. 341 indexed citations

17.

Herbst, Karen L., Andrea D. Coviello, Stephanie T. Page, et al.. (2004). A Single Dose of the Potent Gonadotropin-Releasing Hormone Antagonist Acyline Suppresses Gonadotropins and Testosterone for 2 Weeks in Healthy Young Men. The Journal of Clinical Endocrinology & Metabolism. 89(12). 5959–5965. 57 indexed citations

18.

Herbst, Karen L., Bradley D. Anawalt, John K. Amory, Alvin M. Matsumoto, & William J. Bremner. (2003). The Male Contraceptive Regimen of Testosterone and Levonorgestrel Significantly Increases Lean Mass in Healthy Young Men in 4 Weeks, but Attenuates a Decrease in Fat Mass Induced by Testosterone Alone. The Journal of Clinical Endocrinology & Metabolism. 88(3). 1167–1173. 27 indexed citations

19.

Amory, John K., Howard A. Chansky, Kari Chansky, et al.. (2002). Preoperative Supraphysiological Testosterone in Older Men Undergoing Knee Replacement Surgery. Journal of the American Geriatrics Society. 50(10). 1698–1701. 63 indexed citations

20.

Amory, John K. & Bradley D. Anawalt. (2001). Male hormonal contraceptives. Expert Opinion on Pharmacotherapy. 2(9). 1389–1398. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact